id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-1001-0010,FDA,FDA-1998-N-1001,Response Letter from FDA CDER to Cumulus Pharmaceutical LL (Carbomer),Other,Response(s),2022-09-13T04:00:00Z,2022,9,2022-09-13T04:00:00Z,,2022-09-13T16:07:23Z,,0,0,09000064852f8d90
FDA-1998-N-1001-0009,FDA,FDA-1998-N-1001,Response Letter from FDA CDER to Cumulus Pharmaceutical LLC (Dexpanthenol),Other,Response(s),2022-09-13T04:00:00Z,2022,9,2022-09-13T04:00:00Z,,2022-09-13T16:04:09Z,,0,0,09000064852f8d8e